The capital infusion was sought by Knight Capital after it bore a loss of nearly four times its net income of $115.2m for 2011 that resulted from a technical snag at the beginning of trading in NYSE listed stocks.
As per the capital infusion deal, the aforesaid group of companies will provide the amount through a convertible share placement that will give them control of the broker, as reported by the Financial Times.
The deal will adversely eradicate the share of existing shareholders and the four acquirers will get nearly 70% of Knight upon conversion of the bond in to shares.
Based in Jersey City, Knight employs 1,423 employees and its major assets include a 19.9% stake in US stock exchange DirectEdge and two electronic trading platforms, BondPoint for fixed income and Hotspot FX for currencies.
